

Volume 2, Issue 4 (Suppl)
Breast Can Curr Res, an open access journal
Breast Pathology 2017
August 23-24, 2017
Page 23
Notes:
conference
series
.com
August 23-24, 2017 Toronto, Canada
4
th
World Congress on
Breast Pathology and Cancer Diagnosis
Nam-Sun Paik, Breast Can Curr Res 2017, 2:4 (Suppl)
DOI: 10.4172/2572-4118-C1-007
Current status of Korean breast cancer and oncoplastic surgery
B
reast cancer is one of most common cancer among Korean women, and still shows annual 6.1% increase and it is the
second most common female cancer since 2006. Common causes of breast cancer includes first birth at late age, early
menarche and late menopause, hormone replacement therapy, high fat and high calorie diet (BMI↑), alcohol abuse, low
physical activity and genetic factors 21,484 in Korea, 2014. The survival rate of breast cancer patient in Korea was much
improved with early detection and new treatment modalities which includes chemotherapy, radiotherapy, immunotherapy,
hormonal therapy, target therapy and multimodality therapy including precision medicine. The 5-year and 10-year survival
was 91.2% and 84.8% respectively. So breast specialists started to consider about patients’ quality of life and developed
new surgical technic (oncoplastic surgery) without change of recurrence and survival. Breast conserving surgery (BCS) has
showed gradually increasing tendency in Korea, currently about 70%, which may be preferable to mastectomy in terms of
psychologically and cosmetically, recently in Korea we have much considered for oncoplastic surgery. The principles of
oncoplastic surgery of the breast are based on complete removal of breast cancer with minimal scarring and producing optimal
breast shape and size. It includes careful preoperative planning as part of a multidisciplinary approach and a surgical plan
that will result in optimal cancer management and the best possible aesthetic outcome. Incidence of breast cancer increases
according to improvement of economic status and women’s environmental factors in Korea. So breast specialists should
consider not only recurrence and survival rate but also QOL with BCS or oncoplastic surgery.
Biography
Nam-Sun Paik had completed his graduation from School of Medicine, Seoul National University in 1973 and is currently the Director of Ewha Womens University
Cancer Center for Women, Seoul Korea from 2011. He served as President of Konkuk University Medical Center from 2009 to 2011, President of Asian Breast
Cancer Society (2006-2008) and was selected as one of the top 100 Health Professionals as of Breast and Stomach Surgical Oncologist, International Biograph-
ical Center of Cambridge, England in 2006. He also served as President of Korean Breast Cancer Society (2001-2003), President of the 3rd Asian Breast Cancer
Society Congress 2000-2001 and was selected as one of the top 100 Health Professional as of Breast and Stomach Surgical Oncologist. Cambridge, England in
2006 and as a Man of the Year, International Biographical Center of Cambridge, England in 2001.
namsun.paik@gmail.comNam-Sun Paik
Ewha Womans Cancer Center Hospital for Women, South Korea